Evidence map›Paper›PMID 42233519›Full record

ArticleAngewandte Chemie (International ed. in English)2026

Enantioselective Synthesis of Axially Chiral Diaryl Ethers via Rhodium-Catalyzed [2 + 2 + 2] Cycloaddition.

Yu Sato, Julong Jiang, Kairi Yamashiro, Ken Tanaka

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yu SatoDepartment of Chemical Science and Engineering, Institute of Science Tokyo, Tokyo, Japan.
Julong JiangInstitute for Chemical Reaction Design and Discovery (WPI-ICReDD), Hokkaido University, Sapporo, Hokkaido, Japan.ORCID https://orcid.org/0000-0002-2357-1127
Kairi YamashiroDepartment of Chemical Science and Engineering, Institute of Science Tokyo, Tokyo, Japan.
Ken TanakaDepartment of Chemical Science and Engineering, Institute of Science Tokyo, Tokyo, Japan.ORCID https://orcid.org/0000-0003-0534-7559

Funding

JSPS KAKENHI JP24H00005JSPS KAKENHI JP24KJ1103
6 · The paper itself

Abstract

Axially chiral diaryl ethers are important structural motifs in biologically active molecules, functional materials, and chiral catalysts. However, their enantioselective synthesis remains challenging because rotation around the Ar-O bond often occurs with relatively low rotational barriers, and most existing methods rely on desymmetrization strategies that inherently limit the accessible substitution patterns. Here we report a rhodium-catalyzed enantioselective [2 + 2 + 2] cycloaddition of triynes bearing alkynyl ether units that provides axially chiral diaryl ethers with high enantioselectivity. In this transformation, benzannulation simultaneously constructs the aromatic ring and restricts rotation about the Ar-O bond while introducing diverse substituents, thereby enabling efficient atroposelective synthesis. The reaction exhibits a broad substrate scope and affords the desired products in good yields and enantioselectivities. In suitably designed substrates, the benzannulation process generates multiple atropisomeric axes in a single step, providing complex stereochemical architectures with up to four stereogenic axes. DFT calculations indicate that steric and dispersion interactions during oxidative cyclization govern the stereochemical outcome, and a stepwise alkyne insertion, featuring shortened Rh-C bonds in the transition state, likely enables efficient stereoinduction within the chiral environment, accounting for the observed high enantioselectivity.

Indexed as

[2 + 2 + 2] cycloadditionalkynyl ethersasymmetric catalysisaxial chiralitydiaryl ethersrhodium

Identifiers

PMID42233519
PMCPMC13427224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.